Hepatitis C News and Research

Latest Hepatitis C News and Research

2022 adult immunization schedule released by ACIP

2022 adult immunization schedule released by ACIP

17 Feb 2022
Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

16 Feb 2022
The emergence of infectious diseases from the "germ’s eye view”

The emergence of infectious diseases from the "germ’s eye view”

16 Feb 2022
New tool appears to accurately identify patients at risk of death from alcohol-associated hepatitis

New tool appears to accurately identify patients at risk of death from alcohol-associated hepatitis

15 Feb 2022
Prediction of SARS-CoV-2 epitope candidates for future vaccines

Prediction of SARS-CoV-2 epitope candidates for future vaccines

15 Feb 2022
The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

15 Feb 2022
Researchers generate stable cell lines capable of producing various hepatitis B virus genotypes

Researchers generate stable cell lines capable of producing various hepatitis B virus genotypes

15 Feb 2022
Discovery may lead to new treatment approach for people with alcohol-associated liver disease

Discovery may lead to new treatment approach for people with alcohol-associated liver disease

14 Feb 2022
Hundreds of new proteins that could play a role in cystic fibrosis discovered

Hundreds of new proteins that could play a role in cystic fibrosis discovered

14 Feb 2022
Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

12 Feb 2022
Study finds 50% increase in hospitalizations for alcoholic hepatitis in early months of the pandemic

Study finds 50% increase in hospitalizations for alcoholic hepatitis in early months of the pandemic

9 Feb 2022
Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

4 Feb 2022
Nuvaxovid COVID-19 vaccine given regulatory approval By MHRA

Nuvaxovid COVID-19 vaccine given regulatory approval By MHRA

3 Feb 2022
Hepatitis E virus can resist most common hand disinfectants, research shows

Hepatitis E virus can resist most common hand disinfectants, research shows

1 Feb 2022
Researchers develop new tool to determine patients' liver cancer risk after hepatitis C

Researchers develop new tool to determine patients' liver cancer risk after hepatitis C

28 Jan 2022
Two-step strategy can help determine the risk of liver cancer after HCV cure

Two-step strategy can help determine the risk of liver cancer after HCV cure

27 Jan 2022
Study demonstrates differential alternative splicing in betacoronaviruses

Study demonstrates differential alternative splicing in betacoronaviruses

26 Jan 2022
Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

25 Jan 2022
Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

25 Jan 2022
Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

25 Jan 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback